atRA deficiency in colon cancer is driven by microbiota-induced inflammation
Treatment with atRA reduces tumorigenesis by enhancing a CD8+ T cell response
The enhanced CD8+ T cell response is due to upregulation of MHCI on tumor cells
CD8+ T cell cytotoxicity in human colon cancer correlates with local atRA metabolism